Published in J Virol Methods on July 01, 1994
Determinants of RNA quality from FFPE samples. PLoS One (2007) 2.69
mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol (2011) 2.20
RNA expression analysis from formalin fixed paraffin embedded tissues. Histochem Cell Biol (2008) 2.13
Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. J Mol Diagn (2013) 1.59
RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies. BMC Mol Biol (2007) 1.45
Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin Cancer Res (2009) 1.40
Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens. J Mol Diagn (2010) 1.27
Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer (2011) 1.20
The impact of microRNAs on colorectal cancer. Virchows Arch (2009) 1.20
Detection of hepatitis C virus RNA using ligation-dependent polymerase chain reaction in formalin-fixed, paraffin-embedded liver tissues. Am J Pathol (1996) 1.12
Successful protein extraction from over-fixed and long-term stored formalin-fixed tissues. PLoS One (2011) 1.08
Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol (1995) 1.01
MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples. BMC Cancer (2013) 1.01
High stability of microRNAs in tissue samples of compromised quality. Virchows Arch (2013) 0.98
Tissue fixation and the effect of molecular fixatives on downstream staining procedures. Methods (2014) 0.97
MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer. Radiol Oncol (2013) 0.90
Molecular insight into the association between cartilage regeneration and ear wound healing in genetic mouse models: targeting new genes in regeneration. G3 (Bethesda) (2013) 0.88
Fluorescent Reporter Signals, EGFP, and DsRed, Encoded in HIV-1 Facilitate the Detection of Productively Infected Cells and Cell-Associated Viral Replication Levels. Front Microbiol (2012) 0.85
Molecular detection and serotypic analysis of enterovirus RNA in archival specimens from patients with acute myocarditis. Br Heart J (1995) 0.84
Demonstration of bovine herpesvirus type 1 and Mannheimia haemolytica antigens in specimens stored for up to 22 months in buffered formalin. Can J Vet Res (2002) 0.82
A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds. PLoS One (2015) 0.78
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer. BMC Med Genomics (2016) 0.77
Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in Pakistan. Diagn Pathol (2011) 0.77
Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue. PLoS One (2017) 0.75
Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell (1984) 5.56
Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet (1990) 4.99
Sexual transmission of hepatitis C virus. Lancet (1993) 4.27
Hepatitis C virus six years on. Lancet (1994) 4.09
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet (1991) 3.97
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J (1984) 3.28
Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet (1993) 3.20
White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods. Vox Sang (2005) 2.77
Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut (1986) 2.74
Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer (1993) 2.60
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J (1985) 2.47
Prevention of Yersinia enterocolitica growth in red-blood-cell concentrates. Lancet (1992) 2.44
The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell (1986) 2.06
Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C. Ann Intern Med (1996) 2.05
Expression of the nuclear oncogene p53 in colon tumours. J Pathol (1989) 2.05
Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus. Lancet (1986) 2.04
Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin. Lancet (1979) 2.03
Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol (1994) 2.02
Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J (Clin Res Ed) (1983) 1.86
Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J Virol (1991) 1.83
Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet (1989) 1.82
Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis (2005) 1.80
Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet (1982) 1.74
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Chlamydia trachomatis and ectopic pregnancy: retrospective analysis of salpingectomy specimens, endometrial biopsies, and cervical smears. J Clin Pathol (1995) 1.69
Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer (1994) 1.67
Cloned human snRNP proteins B and B' differ only in their carboxy-terminal part. EMBO J (1989) 1.59
Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood (1990) 1.59
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis (2006) 1.56
Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease. Br J Surg (2000) 1.55
Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol (1992) 1.49
[Surgical treatment of ulcerative colitis and familial adenomatous polyposis: recent developments]. Ned Tijdschr Geneeskd (1999) 1.43
Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection. Vox Sang (1989) 1.43
Dangers of dietary germanium supplements. Lancet (1990) 1.42
Cord blood banking. Vox Sang (2008) 1.41
International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods (1996) 1.41
Functional results and visceral perception after ileo neo-rectal anastomosis in patients: a pilot study. Gut (2001) 1.40
New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion (1998) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
The ileo neorectal anastomosis: an experimental study on development of the surgical technique and theoretical background. Colorectal Dis (2001) 1.39
[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]. Ned Tijdschr Geneeskd (2005) 1.39
New anti-human immunodeficiency virus immunoblot assays resolve nonspecific western blot results. Transfusion (1997) 1.38
Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis. Eur J Gastroenterol Hepatol (1999) 1.37
Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines. J Gen Virol (1987) 1.36
Upstream regions of the hamster desmin and vimentin genes regulate expression during in vitro myogenesis. EMBO J (1987) 1.36
Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO J (1989) 1.35
Donors with a rare pheno (geno) type. Vox Sang (2008) 1.35
Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol (1992) 1.33
Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probes. J Virol (1986) 1.24
Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol (2001) 1.23
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22
Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang (2003) 1.22
Blood donations reactive for HIV in Western blot, but non-infective in culture and recipients of blood. Lancet (1986) 1.18
Bacterial contamination in platelet concentrates. Vox Sang (2014) 1.18
Evaluation of a new haemagglutination technique for the demonstration of hepatitis-B antigen. Lancet (1973) 1.18
Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial. Lancet (1983) 1.17
Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sang (2011) 1.16
Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands. Vox Sang (1991) 1.15
Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus. Transfusion (1995) 1.15
The primary structure of leucine aminopeptidase from bovine eye lens. J Biol Chem (1982) 1.14
Amplified-fragment length polymorphism analysis of Propionibacterium isolates implicated in contamination of blood products. Br J Haematol (2005) 1.13
Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients. Transfusion (1993) 1.09
Early antihepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang (1992) 1.08
[Molecular genetic studies in alpha-thalassemia]. Ned Tijdschr Geneeskd (1992) 1.07
Earlier detection of HIV and second-generation antibody assays. Lancet (1987) 1.05
Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet (1989) 1.04
Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification. J Virol Methods (1998) 1.03
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. J Viral Hepat (2015) 1.02
Intermediate filament formation after transfection with modified hamster vimentin and desmin genes. J Cell Sci (1987) 1.01
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals. J Clin Pathol (2000) 1.00
Resectional surgical procedures for carcinoma of the head of the pancreas. Surg Gynecol Obstet (1989) 1.00
Genetic mapping of Pim-1 putative oncogene to mouse chromosome 17. Somat Cell Mol Genet (1986) 0.99
Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion (1990) 0.98
Deferral of males who had sex with other males. Vox Sang (2011) 0.98
Neonatal transfusions. Vox Sang (2009) 0.97
Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang (1992) 0.96
Evaluation of a simple method for determination of IgG titre anti-A or-B in cases of possible ABO blood group incompatibility. Vox Sang (1972) 0.96
Risk of virus transmission by tissue, blood, and plasma products. Transplant Proc (1996) 0.95
Gastrointestinal involvement in Langerhans' cell histiocytosis (Histiocytosis X): a clinical report of three cases. Eur J Pediatr (1990) 0.94
Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion (1994) 0.93
Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. J Clin Gastroenterol (1988) 0.92
Glomerular lesions and opportunistic infections of the kidney in AIDS: an autopsy study of 47 cases. Adv Exp Med Biol (1989) 0.92
Mother-to-infant transmission and hepatitis C virus. Lancet (1990) 0.92
Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT. J Virol Methods (1997) 0.91